NCT03102762View on ClinicalTrials.gov

Botulinum Toxin for Erectile Dysfunction

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

January 3, 2017

Primary Completion Date

January 10, 2019

Study Completion Date

January 10, 2019

Conditions
Sexual DysfunctionErectile Dysfunction
Interventions
DRUG

Botulinum Toxin Type A

Drug: Botulinum Toxin Type A The treatment group will be injected with 100 units BTX-A one day following penile colour doppler assessment.

DRUG

Normal saline

The treatment group will be injected with 1 ml normal saline one day following penile colour doppler assessment.

Trial Locations (1)

11231

Department of Andrology, Cairo University, Cairo

All Listed Sponsors
lead

Cairo University

OTHER

NCT03102762 - Botulinum Toxin for Erectile Dysfunction | Biotech Hunter | Biotech Hunter